IMPAX LABORATORIES INC·4

Mar 13, 12:33 PM ET

Mengler Christopher 4

4 · IMPAX LABORATORIES INC · Filed Mar 13, 2009

Insider Transaction Report

Form 4
Period: 2009-03-05
Mengler Christopher
President, Global Pharm. Div.
Transactions
  • Purchase

    Common Stock

    2009-03-12$5.50/sh+5,000$27,50045,000 total
  • Award

    Common Stock

    2009-03-05+30,00040,000 total
  • Award

    Employee Stock Option (Right to Buy)

    2009-03-05+75,00075,000 total
    Exercise: $6.00Exp: 2019-03-05Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]The option becomes exercisable in four equal annual installments beginning on March 5, 2010, which is the first anniversary of the date on which the option was granted.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION